Close Menu

NEW YORK (GenomeWeb) – Biocept reported after the close of the market Thursday that its third quarter revenues rose sharply year over year on increased test volume.

The San Diego-based maker of cancer biomarker assays reported total revenues of $164,856 for the three months ended Sept. 30, up from $10,274 for the third quarter of 2014. It said that it accessioned 482 commercial cases during the quarter, nearly five times the 96 commercial cases for the third quarter of 2014.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

23andMe has a holiday popup shop at a mall and could open additional stores, Bloomberg reports.

By studying koalas and a retrovirus that infects them, researchers may have uncovered a new sort of 'immune response' that occurs at the genomic level, Agence France Presse reports.

NPR reports that the first person in the US given a gene editing-based therapy for a genetic disorder is heading home.

In Science this week: ancient genomes reveal social inequality within individual households, new method for quantifying genetic variation in gene dosage, and more.